Heart Disease at 30, AI-Discovered Cures, and Reversed Alzheimer’s: Longevity Medicine’s Landmark Week
Three landmark developments are rewriting the rules of longevity medicine: cardiovascular prevention now starting at age 30, an AI platform published in Cell discovering treatments for liver cancer and pulmonary fibrosis, and a compound that fully reverses advanced Alzheimer’s disease in animal models. The convergence of precision diagnostics, AI-accelerated drug discovery, and cellular energy science marks a turning point in the science of aging.
